The groundbreaking success of Viagra undeniably revolutionized the drug landscape, but betting in companies primarily reliant on unbranded versions presents a complex picture. Although early returns were significant, the cessation of patents and the emergence of cheaper alternatives have eroded sales. Consequently, a thorough evaluation of current